Where does 20/20 Vision Center, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), 20/20 Vision Center, LLC ranks #23,738 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does 20/20 Vision Center, LLC hold?

20/20 Vision Center, LLC holds 11 US utility patents granted between 2016 and 2023, spanning 4 technology areas.

What is 20/20 Vision Center, LLC's Innovation Score?

20/20 Vision Center, LLC has an Innovation Score of 30.4 out of 100 (34th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does 20/20 Vision Center, LLC focus on?

20/20 Vision Center, LLC's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 11 patents, ranking #1,592 of 7,127 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is 20/20 Vision Center, LLC's patent grant rate increasing or decreasing?

20/20 Vision Center, LLC's recent grant velocity is +350% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for 20/20 Vision Center, LLC's patents?

20/20 Vision Center, LLC's patents average 21.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the 20/20 Vision Center, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

20/20 Vision Center, LLC

USPTO PatentsView assignee record - 11 granted patents across 4 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, 20/20 ranks #23,738 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 4 technology areas.

#23,738
of 49,997 US assignees by volume: 34th percentile
by Innovation Score (30.4/100): 21.4
avg claims per patent: +350%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23738 · US Corporation #23,738 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #23,738/49,997
PHOTO-FINISH 1316
CPC-NARROW A61B · 4 areas
INNOV-THIN 30.4/100
CLAIMS-DENSE 21.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +350% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: 1316 LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How 20/20’s 30.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (28%) Velocity 1.9 pts (6%) Breadth 7.1 pts (23%) Claim depth 12.8 pts (42%)

Qualcomm Incorporated · highest

85
20/20 Vision Center · this assignee

30
3D Lighting… · lowest

7

What this shows 20/20's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for 20/20?

Each dot is one of 20/20’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). 20/20’s own 21.4 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

20/20 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where 20/20's grants concentrate

20/20 Vision Center, LLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (5 grants) versus a trough of 1 in 2016. By volume, 20/20 sits between 1316 LLC and 3NT Medical Ltd..

20/20's three-year grant acceleration

20/20 Vision Center, LLC shows 2 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

1316

11
1842728 Ontario

11
1867361 Ontario

11
1globe Health Ins…

11
2J Antennas USA

11
3-east

11
3D at Depth

11
3NT Medical

11
20/20 Vision Cent… ◀

11

What this shows 20/20 holds 11 patents at rank #23,738, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near 20/20

By rank, the assignees closest to #23,738 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in 20/20's primary technology class.

20/20's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 34th percentile higher than 34% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

20/20 Vision Center, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	9.1%
2018	1	9.1%
2020	5	45.5%
2021	2	18.2%
2022	1	9.1%
2023	1	9.1%

Which technologies does 20/20 Vision Center, LLC patent most?

A61B - DIAGNOSIS; SURGERY; Identification 11

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 11

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 2

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

20/20 Vision Center, LLC's patent record in context - here's where to go next.

20/20 Vision Center, LLC's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #23,738 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare 20/20 Vision Center, LLC against 1316 LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.